Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Post by imatryinon Feb 01, 2019 8:06am

192 Views

Post# 29304909

options

Looks like there has been no consistency in terms of the date options have been granted. Last year there were 2.3M options granted at $.395 on Feb 13th. In 2017 it was Feb 28th (1.6M) at $.30 and in 2016 it was 1.4M (Feb 1) at $.73. We could be waiting a month. Guess it all depends when they think they will get the go-ahead from the FDA.

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?